PRA’s project team turned around a challenging neonatal seizure study to enable successful recruitment. The relationships between the sponsor and the PRA clinical team are invaluable to the success of this ongoing study.
The RACE Act: Your next steps start here.
The Research to Accelerate Cures and Equity (RACE) for Children Act went into effect on August 18, 2020 and impacts pediatric cancer drug development.
Missy Hansen, Pediatric Strategy Liaison, Center for Pediatric Clinical Development
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…
Global Pediatric Drug Development Collaboration Part Two
70% of medicines given to children have never been studied in pediatric populations. Children who need treatments represent a relatively small…